Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) touched a new 10-year high of $49.44 on Monday. The company said the U.S. Food and Drug Administration gave priority review status for its new investigational eye solution to treat neovascular form of age-related macular degeneration, or wet AMD, a disorder that causes vision loss due to abnormal growth of blood vessels.
For the first time in 27 years, clinical diagnostic criteria for Alzheimer's disease dementia have been revised, and research guidelines for earlier stages of the disease have been characterized to reflect a deeper understanding of the disorder. The National Institute on Aging/Alzheimer's Association Diagnostic Guidelines for Alzheimer's Disease outline some new approaches
Roche Holding AG's rheumatoid arthritis drug Actemra received approval from the U.S. Food and Drug Administration (FDA) to treat a rare type of arthritis in children.
The U.S. Food and Drug Administration (FDA) has approved a new treatment system manufactured by Neurovasx Inc. for large brain aneurysms. Maple Grove-based Neurovasx's cPAX Aneurysm Treatment System is for surgery on brain aneurysms that are difficult to manage because of their size and shape.
A U.S. Environmental Protection Agency draft assessment of the potential health effects associated with formaldehyde exposure needs substantial revision, says a new report from the National Research Council, which recommends improvements for EPA's final assessment.
The U.S. Food and Drug Administration (FDA) has approved the first test to help diagnose people with signs and symptoms of dengue fever or dengue hemorrhagic fever. Manufactured by Seattle-based Inbios Inc., the DENV Detect IgM Capture ELISA test detects antibodies to dengue virus in blood samples from patients who have signs and symptoms of dengue.
The top pre-market NASDAQ Stock Market gainers are: Tasty Baking, Global Crossing, American Medical Systems Holdings, RAM Energy Resources, and VIVUS. The top pre-market NASDAQ Stock Market losers are: Sina, Medivation, Energy Conversion Devices, JetBlue Airways, and Netflix.
The U.S. Food and Drug Administration (FDA) has approved molecular diagnostics company Cepheid (NASDAQ: CPHD)'s test designed to detect the toxin associated with a common bacterial infection that can cause diarrhea and other serious intestinal conditions and death in severe cases.
Congress is putting the pieces in place to avoid a shutdown by midnight on Friday, temporarily easing the pressure but could find itself in the same crisis a week from now as lawmakers still remain apart on a longer six month budget extension.
XenoPort (NASDAQ: XNPT) and GlaxoSmithKline Plc (LON: GSK) said the U.S. Food and Drug Administration (FDA) has approved Horizant, a treatment for restless legs syndrome (RLS) that the companies developed together.
Shares of Immunogen Inc. (NASDAQ: IMGN) touched a new 52-week high and a 9-year high of $12.03 on Thursday. Roche Holding AG said an experimental drug T-DM1 was effective in a mid-stage study of breast cancer patients whose disease has spread.
The U.S. Food and Drug Administration (FDA) cleared a new device, manufactured by California-based ev3, to treat brain aneurysms without performing open surgery.
A new study published by the American Heart Association has found that about one in 44,000 college athletes suffer sudden cardiac death each year, which is higher than what earlier estimates supposed.
The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, VIVUS, Orexigen Therapeutics, Star Scientific, and Optimer Pharmaceuticals. The top pre-market NASDAQ Stock Market losers are: OmniVision Technologies, DepoMed, TD AMERITRADE Holding, Logitech International, and Check Point Software Technologies.
If experiments going on at the University of Minnesota's heart lab succeed, there could be a way to 'grow your own heart' in due course of time, a development that will find a way around heart transplants that force lifetime use of anti-immunity drugs.
University of North Florida's student newspaper the Spinnaker has run into trouble after printing a picture of simulated oral sex on its front cover.
Indicating the distressing trend of size zero has gone global, a new research has found how stigmatization of fat and obesity has spread from western countries across more accepting cultures.
The FDA found small amounts of radiation in a sample batch of milk from Spokane, Washington. The level, however, was 5,000 times lower than the Derived Intervention Level set by the FDA.
The recent nuclear disaster in Japan has put a spotlight on measuring radiation dosage and the health effects, and how to diagnose thousands of people at a time.
Merck & Co Inc. (NYSE: MRK)'s shingles vaccine Zostavax is now approved by the US Food and Drug Administration (FDA) for people aged 50 and older. Zostavax was originally approved on May 2006 to prevent herpes zoster, commonly known as shingles, in individuals 60 years of age and older.
Prader-Willi syndrome is a rare genetic disorder that’s not very well known. Currently, there is a flurry of interest in this disease due to speculation that a Lu Hao, a 132-pound 3-year-old Chinese boy, may have this disease.
Legendary actress Elizabeth Taylor died Wednesday at the age of 79 in Los Angeles. Her death was caused by a condition she has called congestive heart failure.
